• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者体内非甾体抗炎药的胆汁排泄

Biliary elimination of non-steroidal anti-inflammatory drugs in patients.

作者信息

Schneider H T, Nuernberg B, Dietzel K, Brune K

机构信息

Department of Medicine I, University of Erlangen-Nuernberg, FRG.

出版信息

Br J Clin Pharmacol. 1990 Jan;29(1):127-31. doi: 10.1111/j.1365-2125.1990.tb03613.x.

DOI:10.1111/j.1365-2125.1990.tb03613.x
PMID:2297457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1380072/
Abstract

In view of evidence in animals that enterohepatic recirculation of non-steroidal anti-inflammatory drugs contributes to small intestinal mucosal damage we have investigated the extent of biliary elimination of three nonsteroidals. Ibuprofen (n = 3), diclofenac (n = 2) and indomethacin (n = 3) were given to six patients with a percutaneous transhepatic cholangiodrainage placed in the bile duct system. One patient received all three drugs. The mean biliary elimination of ibuprofen was 0.82% of the given dose compared with 50.41% urinary excretion. When diclofenac or indomethacin was administered 4.62% and 6.40% of the dose were found in bile, whereas 34.73% and 32.22% (means) were recovered from urine, respectively. The mean percentage eliminated in bile as unchanged drug and active phase II metabolites was 0.15% for ibuprofen, 1.09% for diclofenac and 5.02% for indomethacin.

摘要

鉴于动物实验证据表明非甾体抗炎药的肠肝循环会导致小肠黏膜损伤,我们研究了三种非甾体抗炎药的胆汁排泄程度。对6例经皮经肝胆道引流置于胆管系统的患者给予布洛芬(n = 3)、双氯芬酸(n = 2)和吲哚美辛(n = 3)。1例患者接受了所有三种药物。布洛芬的平均胆汁排泄量为给药剂量的0.82%,而尿排泄量为50.41%。给予双氯芬酸或吲哚美辛时,胆汁中分别发现给药剂量的4.62%和6.40%,而尿液中的回收率分别为34.73%和32.22%(均值)。以原形药物和活性II期代谢物形式经胆汁排泄的平均百分比,布洛芬为0.15%,双氯芬酸为1.09%,吲哚美辛为5.02%。

相似文献

1
Biliary elimination of non-steroidal anti-inflammatory drugs in patients.患者体内非甾体抗炎药的胆汁排泄
Br J Clin Pharmacol. 1990 Jan;29(1):127-31. doi: 10.1111/j.1365-2125.1990.tb03613.x.
2
Influence of acute uraemia on percutaneous absorption of nonsteroidal anti-inflammatory drugs.急性尿毒症对非甾体抗炎药经皮吸收的影响。
Acta Univ Palacki Olomuc Fac Med. 1998;141:35-8.
3
Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.在胆总管完全梗阻患者经皮胆道减压后,头孢孟多的胆汁排泄减少。
Antimicrob Agents Chemother. 1984 Dec;26(6):944-6. doi: 10.1128/AAC.26.6.944.
4
The biliary elimination and enterohepatic circulation of ibuprofen in rats.布洛芬在大鼠体内的胆汁排泄及肝肠循环
Pharm Res. 1990 Jan;7(1):87-90. doi: 10.1023/a:1015847912059.
5
[Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].[各种非甾体类抗炎药在白内障囊外摘除术中的抗炎作用及房水浓度]
Klin Monbl Augenheilkd. 1996 Mar;208(3):161-6. doi: 10.1055/s-2008-1035191.
6
Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved.抗炎药物诱导大鼠胃肠道溃疡形成。相关的物理化学和生化因素。
Arch Toxicol. 1990;64(3):210-7. doi: 10.1007/BF02010727.
7
Biliary elimination of indomethacin in man.吲哚美辛在人体中的胆汁排泄。
Eur J Clin Pharmacol. 1986;29(6):691-5. doi: 10.1007/BF00615960.
8
In vitro effect of different non-steroidal anti-inflammatory drugs on human polymorphonuclear leukocyte activity measured by luminol-dependent chemiluminescence of the whole blood.通过全血鲁米诺依赖性化学发光法测定不同非甾体抗炎药对人多形核白细胞活性的体外作用。
Saudi Med J. 2001 Apr;22(4):360-5.
9
Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury.吲哚美辛经胆汁排泄在胃肠道及肝脏损伤中的重要性。
J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e384-9. doi: 10.1111/j.1440-1746.2007.05266.x. Epub 2007 Dec 13.
10
Influence of pentobarbitone on in-vivo local disposition of diclofenac in rat liver.戊巴比妥对双氯芬酸在大鼠肝脏内局部分布的影响。
J Pharm Pharmacol. 1996 Aug;48(8):866-9. doi: 10.1111/j.2042-7158.1996.tb03989.x.

引用本文的文献

1
Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations.右旋布洛芬的治疗进展:前药与纳米技术制剂
Pharmaceutics. 2021 Mar 19;13(3):414. doi: 10.3390/pharmaceutics13030414.
2
Experimental study of diclofenac and its biliary metabolites on anastomotic healing.双氯芬酸及其胆汁代谢产物对吻合口愈合的实验研究
BJS Open. 2018 May 17;2(4):220-228. doi: 10.1002/bjs5.63. eCollection 2018 Aug.
3
Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak in Rats.微生物葡萄糖醛酸酶抑制可减轻双氯芬酸诱导的大鼠吻合口漏的严重程度。
Surg Infect (Larchmt). 2018 May/Jun;19(4):417-423. doi: 10.1089/sur.2017.245. Epub 2018 Apr 6.
4
Pain management for dentists: the role of ibuprofen.牙医的疼痛管理:布洛芬的作用
Ann Stomatol (Roma). 2011 Jul;2(3-4 Suppl):3-24. Epub 2012 Apr 15.
5
Ibuprofen: pharmacology, efficacy and safety.布洛芬:药理学、疗效和安全性。
Inflammopharmacology. 2009 Dec;17(6):275-342. doi: 10.1007/s10787-009-0016-x. Epub 2009 Nov 21.
6
Methods to evaluate biliary excretion of drugs in humans: an updated review.评估人体药物胆汁排泄的方法:最新综述
Mol Pharm. 2006 May-Jun;3(3):198-211. doi: 10.1021/mp060011k.
7
In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats.
Dig Dis Sci. 2000 Jul;45(7):1359-65. doi: 10.1023/a:1005508120776.
8
Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F1 alpha and leukotriene B4 level in relation to gastroenteropathy.与胃肠病相关的临床相关剂量消炎痛长期治疗对肠道组织6-酮前列腺素F1α和白三烯B4水平的影响。
Inflammation. 1998 Jun;22(3):243-52. doi: 10.1023/a:1022354614385.
9
Clinical pharmacokinetics of ibuprofen. The first 30 years.布洛芬的临床药代动力学。头30年
Clin Pharmacokinet. 1998 Feb;34(2):101-54. doi: 10.2165/00003088-199834020-00002.
10
Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.双氯芬酸的临床药代动力学。治疗见解与陷阱。
Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003.

本文引用的文献

1
High-performance liquid chromatographic method for the determination of indomethacin and its two primary metabolites in urine.高效液相色谱法测定尿液中吲哚美辛及其两种主要代谢物
J Chromatogr. 1984 Mar 9;306:315-21. doi: 10.1016/s0378-4347(00)80893-2.
2
FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs.
Arthritis Rheum. 1985 Oct;28(10):1168-9. doi: 10.1002/art.1780281014.
3
High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids.高效液相色谱法测定生物流体中双氯芬酸及其单羟基化代谢物
J Chromatogr. 1985 Feb 27;338(1):151-9. doi: 10.1016/0378-4347(85)80079-7.
4
Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.因小肠或大肠穿孔及出血入院的患者使用抗炎药物的情况。
Br Med J (Clin Res Ed). 1985 Feb 2;290(6465):347-9. doi: 10.1136/bmj.290.6465.347.
5
Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics.上消化道大出血。与阿司匹林及其他非麻醉性镇痛药使用的关系。
Arch Intern Med. 1988 Feb;148(2):281-5. doi: 10.1001/archinte.148.2.281.
6
Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs.
J Rheumatol Suppl. 1988 Oct;17:44-57.
7
High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids.高效液相色谱法测定生物流体中的布洛芬、其代谢物及对映体。
J Chromatogr. 1989 Jun 30;491(1):139-49. doi: 10.1016/s0378-4347(00)82827-3.
8
Enterohepatic circulation of indomethacin and its role in intestinal irritation.吲哚美辛的肠肝循环及其在肠道刺激中的作用。
Biochem Pharmacol. 1975 Oct 1;24(19):1749-54. doi: 10.1016/0006-2952(75)90450-5.